Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Policy disparities in response to the first wave of COVID-19 between China and Germany.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Zhang Y;Zhang Y; Shi L; Shi L; Chen H; Chen H; Wang X; Wang X; Sun G; Sun G; Sun G
  • المصدر:
    International journal for equity in health [Int J Equity Health] 2021 Mar 25; Vol. 20 (1), pp. 86. Date of Electronic Publication: 2021 Mar 25.
  • نوع النشر :
    Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101147692 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-9276 (Electronic) Linking ISSN: 14759276 NLM ISO Abbreviation: Int J Equity Health Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2002-
    • الموضوع:
      COVID-19/*epidemiology ; COVID-19/*prevention & control ; Communicable Disease Control/*legislation & jurisprudence ; Health Policy/*legislation & jurisprudence ; Pandemics/*legislation & jurisprudence ; Pandemics/*prevention & control ; Public Health/*legislation & jurisprudence; Adult ; Aged ; Aged, 80 and over ; China/epidemiology ; Female ; Germany/epidemiology ; Humans ; Male ; Middle Aged ; SARS-CoV-2
    • نبذة مختصرة :
      Objective: Our research summarized policy disparities in response to the first wave of COVID-19 between China and Germany. We look forward to providing policy experience for other countries still in severe epidemics.
      Methods: We analyzed data provided by National Health Commission of the People's Republic of China and Johns Hopkins University Coronavirus Resource Center for the period 10 January 2020 to 25 May 252,020. We used generalized linear model to evaluate the associations between the main control policies and the number of confirmed cases and the policy disparities in response to the first wave of COVID-19 between China and Germany.
      Results: The generalized linear models show that the following factors influence the cumulative number of confirmed cases in China: the Joint Prevention and Control Mechanism; locking down the worst-hit areas; the highest level response to public health emergencies; the expansion of medical insurance coverage to suspected patients; makeshift hospitals; residential closed management; counterpart assistance. The following factors influence the cumulative number of confirmed cases in Germany: the Novel Coronavirus Crisis Command; large gathering cancelled; real-time COVID-19 risk assessment; the medical emergency plan; schools closure; restrictions on the import of overseas epidemics; the no-contact protocol.
      Conclusions: There are two differences between China and Germany in non-pharmaceutical interventions: China adopted the blocking strategy, and Germany adopted the first mitigation and then blocking strategy; China's goal is to eliminate the virus, and Germany's goal is to protect high-risk groups to reduce losses. At the same time, the policies implemented by the two countries have similarities: strict blockade is a key measure to control the source of infection, and improving medical response capabilities is an important way to reduce mortality.
    • References:
      Lancet. 2020 May 2;395(10234):1417-1418. (PMID: 32325026)
      Brain Behav. 2020 Sep;10(9):e01745. (PMID: 32633464)
      Lancet. 2020 Apr 18;395(10232):1305-1314. (PMID: 32247320)
      Lancet Infect Dis. 2020 May;20(5):533-534. (PMID: 32087114)
      Paediatr Respir Rev. 2020 Sep;35:50-56. (PMID: 32709461)
      Clin Hemorheol Microcirc. 2020;74(4):363-372. (PMID: 32390611)
    • Grant Information:
      16BGL184 National Office for Philosophy and Social Sciences
    • Contributed Indexing:
      Keywords: COVID-19; China; Germany; Global health equity; Nonpharmaceutical intervention
    • الموضوع:
      Date Created: 20210326 Date Completed: 20210412 Latest Revision: 20210412
    • الموضوع:
      20221213
    • الرقم المعرف:
      PMC7993854
    • الرقم المعرف:
      10.1186/s12939-021-01424-3
    • الرقم المعرف:
      33766049